Watching
SG · Sweetgreen, Inc.
Updated ·
Against its published line
Above its line on the last close.
How to read this
The red mark is the published kill line — the price that would prove the thesis wrong. The dot is where the name closed on 9 October 2026; a dot left of the mark has closed through its line.
Distance is drawn on a square-root scale, so close calls get the room. Past 8% a row reads well clear, with a hollow dot to show the figure is off the drawn scale. Rows run tightest first.
Kill line
A weekly close below $7.00, which would put the shares back under their 50-day and 200-day moving averages and undo most of the rally since the CDC's 11 September 2026 all-clear. Separately, a fiscal 2026 guidance cut to comparable sales worse than an 8.0% decline or an adjusted EBITDA loss above $27 million.
Open pick Medium conviction, opened at $9.10. Since then +5.8% against the S&P 500's +1.2% (+4.7 pp). Kill line at open: $7.00 (weekly close); graded by at the latest.
Catalyst (in 24 days)
How picks are graded →The thesis
Sweetgreen's shares have extended their recovery from the summer cyclospora outbreak and now trade well above every published consensus target. The third-quarter report, expected around 5 November 2026, decides whether reported comparable sales and October commentary confirm what broker channel checks describe. Until then, the company's own guidance still describes a damaged year.
The shares closed at $9.57 on 8 October 2026, according to adjusted daily closes. That is up 4.48% from the $9.16 close on 7 October 2026, 6.3% below the 52-week high of $10.21 and 15.7% higher over three months. The 14-day relative strength index (RSI), a momentum gauge where readings above 70 are conventionally called overbought, stood at 92.1 on 8 October 2026.
The recovery narrative is maturing: brokers made their main moves between 8 September 2026 and 29 September 2026, the Motley Fool brought the story to mainstream readers on 1 October 2026, and the 8 October 2026 gain came with no new company announcement. The company's 6 August 2026 guidance still calls for fiscal 2026 comparable restaurant sales down 7.0–8.0% and an adjusted loss before interest, taxes, depreciation and amortization (adjusted EBITDA) of $23–27 million.
Bullish and bearish views on Sweetgreen, Inc.
The bull case on Sweetgreen, Inc. (SG), in brief: The outbreak is officially over. The bear case: Reported margins are still impaired.
Bull case
- The outbreak is officially over. The Centers for Disease Control and Prevention (CDC) declared the cyclospora outbreak over on 11 September 2026, the Motley Fool reported on 1 October 2026. The fourth quarter is the first full quarter without active outbreak headlines.
- Traffic was healing before the outbreak. On the 6 August 2026 second-quarter call, management said comparable transactions improved from down 11.2% in the first quarter to about down 3% in April and May and roughly flat in June. A recovery would return to that trend.
- Channel checks point to a September recovery. Wells Fargo upgraded the shares to Overweight with an $11 target on 28 September 2026, citing checks showing sales recovery gaining traction in September, Bloomberg reported. Wells Fargo also credited the automated Infinite Kitchen format with cutting kitchen labor and speeding orders.
- The high-end targets keep rising. KeyBanc upgraded to Overweight with a $9 target on 8 September 2026. RBC Capital raised its target to $11 from $6.50 on 29 September 2026, J.P. Morgan kept $10 that day, and Bank of America raised its target to $9.10 from $7.60 with a Hold rating on 4 October 2026, according to StockAnalysis.
- The Wonder stake adds asset value. Wells Fargo's $11 target values the business at 18 times projected fiscal 2028 EBITDA and adds $2 per share for Sweetgreen's stake in Wonder (Bloomberg, 28 September 2026).
Bear case
- Reported margins are still impaired. The 6 August 2026 second-quarter release showed revenue of $192.7 million and comparable sales down 6.2%. Restaurant-level profit margin was 13.1%, against 18.9% a year earlier.
- The third quarter carries the worst damage. On the 6 August 2026 call, management attributed 6 to 7 percentage points of third-quarter comparable-sales pressure to the outbreak. It put the full-year adjusted EBITDA impact at $7–10 million.
- The price sits far above consensus. MarketBeat showed a Hold consensus from 18 analysts (6 Buy, 9 Hold, 3 Sell) and a $7.72 average target on 8 October 2026. StockAnalysis showed an $8.00 consensus from 14 analysts on 7 October 2026. TD Cowen kept Hold with a $6 target on 11 September 2026.
- Momentum is stretched. The RSI of 92.1 on 8 October 2026 follows 92.6 on 6 October 2026. MarketBeat listed the 50-day moving average at $7.02 and the 200-day at $7.24 on 8 October 2026, leaving the shares far above both.
- The second quarter missed estimates. MarketBeat reported a loss of $0.22 per share against a $0.13 estimate and revenue of $192.66 million against $194.50 million for the quarter reported on 6 August 2026.
Price setup
The shares closed at $9.57 on 8 October 2026, up from $9.14 on 6 October 2026 and $9.10 on 2 October 2026, according to adjusted daily closes. The 52-week high is $10.21. The 50-day moving average of $7.02 sits below the 200-day of $7.24 (MarketBeat, 8 October 2026), so the longer averages have not yet caught up with the September rally.
Crowding is visible. Benzinga listed Sweetgreen among ten consumer discretionary names with unusually large options trades on 7 October 2026. MarketBeat put beta at 2.16 and market value at $1.12 billion on 8 October 2026, so single-day swings of several percent are routine. The earnings report sits about four weeks out, and the shares carry an RSI above 90 into it.
$7.00 is the level that matters on the downside. A weekly close below it would put the shares back under both long moving averages and erase most of the gain since the CDC's 11 September 2026 all-clear.
Catalysts, next 30 days
- ~14 October 2026, est.: Company announcement of the third-quarter report date. Sweetgreen announced last year's third-quarter date on 7 October 2025 for a 6 November 2025 report (Business Wire).
- ~5 November 2026, est.: Third-quarter 2026 results and call. Comparable sales, restaurant-level margin, any change to the fiscal 2026 outlook and October quarter-to-date commentary show whether the September channel checks hold.
What would change the view
The case breaks if the third-quarter report cuts the fiscal 2026 outlook again, to comparable sales worse than an 8.0% decline or an adjusted EBITDA loss above $27 million. Management describing October quarter-to-date comparable sales as still clearly negative would also undercut the recovery view. A downgrade or target cut from Wells Fargo, RBC Capital or J.P. Morgan before the report would remove the main support for the rally.
On price, a weekly close below $7.00 ends the thesis. A new public health notice or supplier recall tied to Sweetgreen's produce supply chain would reset the story to the summer.
What it trades with
Sweetgreen trades in the consumer-discretionary rotation group with VRA, GME, FOSL, JILL, LUXE, SIG, ONON and ASO. That group's status has read maturing in each weekly check since 20 September 2026, which raises the bar for a single-name rally to keep running on group buying. The stock's own driver is company-specific: outbreak recovery and the November report. With beta at 2.16 (MarketBeat, 8 October 2026), a broad market sell-off would hit the shares harder than the index regardless of restaurant traffic.
Notes
- Dual-class structure: super-voting Class B shares held by the founder group concentrate control and reduce activist or takeover pressure on Class A holders.
- GAAP earnings per share are distorted by prior-year divestiture gains; comparable sales, restaurant-level margin and adjusted EBITDA are the cleaner operating measures.
- Company SEC risk disclosures name cyclospora and say fresh in-restaurant prep carries more contamination exposure than commissary-based models.
- The shares are high-beta: MarketBeat listed beta at 2.16 and market value at $1.12 billion on 8 October 2026, so large single-day moves are common.
Related · shared themes
AOUT
American Outdoor Brands, Inc.
American Outdoor Brands' 53.0% gross margin, raised profit guidance and $10 million buyback still support the shares, which closed at $16.30 on 8 October 2026; the fiscal second-quarter report, expected around 3 December 2026, shows whether that margin holds.
CRSR
Corsair Gaming, Inc.
Corsair Gaming's margin recovery has lifted profit estimates and a 38.2% three-month share gain; the third-quarter report, estimated for 3 November 2026, decides whether margins hold without the tariff refund and against rising memory costs.
GME
GameStop Corp. Class A
GameStop's CEO Ryan Cohen has bought shares four times on the open market since 10 September, at rising prices, backing a cash-rich balance sheet and fast-growing collectibles sales. EBay's 4 November report and GameStop's December results decide whether the case holds.
ODD
ODDITY Tech Ltd.
ODDITY Tech's guidance for third-quarter revenue down only about 5%, set on 9 September 2026 after beating its own second-quarter targets, keeps the beauty company a recovery case; the third-quarter report, expected around 17 November 2026, decides it.
See also · stocks to watch